Browse
Submit Data
Databases
API
Help

Dataset Information

22 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Colon Capsule Endoscopy as an Alternative to CT-colonography in Colorectal Cancer Screening

ABSTRACT: Interventions: Colon Capsule Endoscopy Primary outcome(s): To evaluate the applicability of CCE in colorectal cancer screening in terms of: diagnostic yield, participation rate, patients’ expected and perceived burden of CCE, the workability of CCE for the staff and the interobserver variability in reviewing the CCE images. Interested patients who meet all inclusion- and exclusion criteria will get an appointment to undergo Colon Capsule Endoscopy. Patients expected and perceived burden of CCE will be measured by 2 questionnaires, one prior to the procedure and one afterwards. The workability for the staff will be measured by a questionnaire which will be handed out to all staff working with CCE within this trial. Study Design: N/A: single arm study, Open (masking not used), N/A , unknown, Other

DISEASE(S): This Study Focuses On Colorectal Cancer Screening (including The Diagnostic Yield For Polyps And Colorectal Cancer)

PROVIDER: 2443282 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure

Project description:This study is designed to determine the optimal bowel preparation regimen for PillCam COLON 2 Capsule Endoscopy System (CCE) procedures in average risk patients. Patients will be randomized to receive one of two bowel preparation regimens prior to PillCam CCE.

| 2192859 | ecrin-mdr-crc

Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.

Project description:The primary objective of this multicenter, prospective, randomized study is to assess the diagnostic yield of Colon Capsule Endoscopy (CCE) versus Computed Tomographic Colonography (CTC) in a screening population.

| 2213802 | ecrin-mdr-crc

Technical Feasibility Evaluation of Mucosal Staining During Colon Capsule Endoscopy (CCE) Procedure in Colorectal Cancer (CRC) High Risk Population, When Using MB-MMX

Project description:A prospective, single-center, single-arm, non-randomized, post-market pilot study evaluating the technical feasibility of mucosal staining during COLON2 Capsule Endoscopy (CCE) procedure in population at high risk for Colorectal Cancer (CRC), when using MB-MMX (Methylene Blue). Up to 15 subjects will be enrolled in 1 center located in Spain. Study duration- up to 10 months from study approval.

| 2387981 | ecrin-mdr-crc

A New Method for Colorectal Cancer Screening: Colon Capsule Endoscopy Compared to Conventional Endoscopy

Project description:Introduction: Prevention of colorectal cancer (CRC) is feasible through polypectomy on screening colonoscopy. Patient acceptance remains the main limiting factor for execution. Colon capsule endoscopy (CCE) might be a novel method for large populations. Aims and methods: Patients referred for screening means or lower gastrointestinal complaints were included in this single center pilot study. They underwent preparation and then ingested the capsule (PillCam Colon). Standard colonoscopy was performed the next morning. Significance was defined as polyps >5mm in size. Performance of exams was by independent physician with blinding of results.

| 2079066 | ecrin-mdr-crc

Safety Of ColoRectal Assessment and Tumor Evaluation by Colon Capsule Endoscopy

Project description:Following European guidelines patients undergoing colonoscopy in one of Odense University Hospitals units will now be offered a colon capsule endoscopy (CCE) in case of incomplete examinations. Patients formerly referred to colonoscopy in general anesthesia or patients who decline colonoscopy after having completed bowel preparation will also be offered a CCE. In our department we have conducted a comparison study documenting that the sensitivity of CCE is superior to CT colonography in both polyps >9 mm and polyps >5 mm, which is also supported by an Italian study. The safety and completion rate of CCE following incomplete colonoscopy is confirmed by several studies including one multicenter study and the completion rate is not significantly lower compared to other patient groups. In an incomplete colonoscopy it is always the most oral part of the colon which is not visualized, whereas in CCE, an incomplete investigation will most often have visualized the oral part. By combining incomplete colonoscopy results and incomplete CCE results we can identify patients who have had a complete colon investigation although both investigations were incomplete. Aim: to investigate the quality of CCE and the completion rate in patients who have undergone an incomplete colonoscopy, have completed bowel preparation but declines colonoscopy or have been referred to colonoscopy in general anesthesia.

| 2333052 | ecrin-mdr-crc

How host-like signals drive gene expression and gene expression drives capsule growth in Cryptococcus neoformans [ep_titration]

Project description:Cryptococcus neoformans is a fungal pathogen with a polysaccharide capsule that becomes greatly enlarged in the mammalian host and during in vitro growth in response to host-like conditions. To understand how individual host-like signals affect capsule size and gene expression, we grew cells wild-type KN99 cells with either no added cyclic AMP (cAMP), 1.1 mM, 1.8 mM, 3.3 mM, 11 mM, or 20 mM cAMP. capsule thickness at 1440 min. We also took samples for RNA-Seq at 30, 90, 180, 1440 minutes and carried out RNA-Seq in quadruplicate. We also measured capsule thickness at 1440 min.

2023-08-02 | GSE226637 | GEO

Deinococcus radiodurans recovery after vacuum exposure

Project description:D. radiodurans was subjected to vacuum for 90 days. Afterwards cells were re-cultivated for 3 h and 6 h, extracted and measured on a LC-orbitrap.

2019-07-19 | PXD011868 | Pride

How host-like signals drive gene expression and gene expression drives capsule growth in Cryptococcus neoformans [ep_pert]

Project description:Cryptococcus neoformans is a fungal pathogen with a polysaccharide capsule that becomes greatly enlarged in the mammalian host and during in vitro growth in response to host-like conditions. To understand how individual host-like signals affect capsule size and gene expression, we grew wild-type cells and cells lacking components of the cAMP pathway: Pde1, Pde2, Pkr1. We also took samples for RNA-Seq at 30, 90, 180, 1440 minutes and carried out RNA-Seq in quadruplicate. We also measured capsule thickness at 1440 min.

2023-08-02 | GSE226651 | GEO

Which bowel preparation regime gives the most optimal Colon Capsule Endocscopy in patients with high risk polyps.

Project description:Primary objectives: The objective of the study is to establish which booster procedure best facilitates timely excretion of CCE. Primary endpoints: Excretion of the Colon Capsule into the toilet

| 2535865 | ecrin-mdr-crc

Extracorporeal magnetic navigation system of capsule endoscopy

Project description:Intervention type:DEVICE Name of intervention:Comparative study between capsule endoscopy and conventional endoscopy on the accuracy and acceptability of gastrointestinal screening Dose form / Japanese Medical Device Nomenclature:DEVICE Capsule endoscopy Route of administration / Site of application:ORAL Dose per administration:1 1 1/unit Dosing frequency / Frequency of use:ONCE ONCE/Examination Planned duration of intervention:8 hours (after ingesting a capsule endoscope) Intended dose regimen:Preparation before and after(booster) ingesting a capsule endoscope, Lubiprostone intake after passing stomach detailes of teratment arms:Volunteers or digestive disease patients who underwent or will undergo upper and lower conventional endoscopy before or after a capsule endoscopy Comparative intervention name:Conventional endoscopic findings before or after capsule endoscopy Dose form / Japanese Medical Device Nomenclature:DEVICE Capsule endoscopy Route of administration / Site of application:ORAL Dose per administration:1 1 1/unit Dosing frequency / Frequency of use:ONCE ONCE Planned duration of intervention:Eight hours after ingesting a capsule endoscope Intended dose regimen:Preparation before and after(booster) ingesting a capsule endoscope Primary outcome(s): Sensitivity and specificity Study Design: Single blind no-randomized trial, uncontrolled control, No, single blind, CONFIRMATORY

| 98701 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data